U.S. Government Talks With Major Drug Companies About Drug Prices
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
TUESDAY, Oct. 3, 2023 -- Pharmaceutical companies that make the 10 prescription drugs chosen to be the first for price negotiations for Medicare patients have agreed to talks with the government.
The Biden administration announced Tuesday that the drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, will take part in price negotiations despite ongoing lawsuits over this same requirement, NBC News reported.
This negotiation is a component of the Inflation Reduction Act, which allows Medicare to work with the drug companies to reduce prices for older Americans. Negotiations are to occur next year with resulting prices going into effect in 2026.
The first 10 drugs named by the Centers for Medicare & Medicaid Services include diabetes drug Januvia, Enbrel for rheumatoid arthritis, and the blood thinners Eliquis and Xarelto. Last year, about 9 million Medicare enrollees paid $3.4 billion out of pocket for these 10 specific drugs, NBC News reported. Additional drugs will later be added to negotiations.
The federal government had given manufacturers one month to decide if they would participate in talks or face tax penalties, NBC News reported. Drugmakers could avoid the penalty if they remove their drug from the Medicare program, but that, too, could be costly.
Companies that are suing, including Merck and Johnson & Johnson, have said that allowing negotiations could affect their profits and, as a result, spending on research and development.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Active Surveillance Effective Strategy for Favorable-Risk Prostate Cancer
FRIDAY, May 31, 2024 -- Active surveillance is an effective management strategy for men with favorable-risk prostate cancer, with an estimated rate of metastasis of 1.4 percent at...
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.